NCT04829604 2026-03-09ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)Ambrx, Inc.Phase 2 Active not recruiting72 enrolled
NCT05011188 2025-08-27FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerUniversity of California, San FranciscoPhase 1/2 Active not recruiting44 enrolled